Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
about
Cytotoxic, apoptotic, and sensitization properties of ent-kaurane-type diterpenoids from Croton tonkinensis Gagnep on human liver cancer HepG2 and Hep3b cell lines.A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells.2,4,6-Trinitrotoluene Induces Apoptosis via ROS-Regulated Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in HepG2 and Hep3B Cells.Selection of internal references for qRT-PCR assays of human hepatocellular carcinoma cell lines.Hypoxia induces the expression of TET enzymes in HepG2 cells.Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells.Three New Iridoid Derivatives Have Been Isolated from the Stems of (Havil.) Merr. with Cytotoxic Activity on Hepatocellular Carcinoma CellsCytotoxic Effect of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) on Liver Cancer Cell Integrated with Hepatitis B Genome, Hep3B
P2860
Q38808287-E9E5C077-1FDD-4947-AED1-383E808A8238Q40175945-684CD15F-0CA2-46FD-8ED5-9D53792EB2A3Q41421031-01EF9209-400D-407F-A0AE-5554B444FA0BQ47123408-C3E41C88-83A5-4E6E-A23D-DD03CA6E53D7Q47146112-177C4A78-33C4-4C12-9292-1B974FB879F6Q48215818-5C7189DF-9D54-4F5C-AC1B-913A414DF43FQ58691318-B5211ED0-543E-4C9D-A042-70A7CAEE4399Q58773062-AC346B80-7A94-409F-948C-C10A3F2FF553
P2860
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
@ast
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
@en
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
@nl
type
label
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
@ast
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
@en
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
@nl
prefLabel
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
@ast
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
@en
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.
@nl
P2093
P2860
P1433
P1476
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B
@en
P2093
Linhong Deng
Xiaohao Shi
Xiaojin Xie
P2860
P2888
P356
10.1007/S10616-014-9761-9
P50
P577
2014-07-08T00:00:00Z
P5875
P6179
1047600073